Delivery Order SPE2DB22D1017-SPE2DB25FF3VM

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,226.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medical product. The award is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,091.33 firm fixed-price delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 4S, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,003.40 firm fixed-price delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medical product, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $15,978.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a medical product, and has an ultimate completion date of October 30, 2024. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,179.88 delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a specialized medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,232.38, is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 4S, a medication used for the treatment of various medical conditions. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This contract award, valued at $1,281.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medication patch, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a prescription medication, with a ceiling value of $1,245.85. The contract has an ultimate completion date of January 28, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,189.17, is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a type of medication. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $4,938.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a medical product. The contract has a completion date of March 15, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov)...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF3VM
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1017|SPE2DB25FF3VM, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $2,240.58, is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a pharmaceutical product.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed did not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:25 AM